Business Context and Reporting Period
Company: Atlantic Union Bankshares Corp (AUB)
Filing Type: Form 8-K (Current Report)
Date: January 24, 2025
Subject: Supplemental disclosures regarding the proposed merger with Sandy Spring Bancorp, Inc. ("Sandy Spring") and response to shareholder litigation.
On October 21, 2024, Atlantic Union entered into a Merger Agreement to acquire Sandy Spring. This filing supplements the joint proxy statement/prospectus (effective December 17, 2024) in response to three shareholder lawsuits and demand letters alleging false/misleading disclosures and fiduciary breaches. The companies deny all allegations but are providing additional details to avoid delaying the transaction.
Key Financial Metrics and Transaction Terms
Transaction Structure: All-stock merger. Sandy Spring shareholders will receive 0.900 shares of Atlantic Union common stock for each share of Sandy Spring common stock.
Valuation and Premiums:
- Implied Premium: 14.2% based on September 3, 2024 closing prices; 10.2% based on September 9, 2024 closing prices.
- Implied Value: $34.93 per share of Sandy Spring common stock (as of October 18, 2024).
Capital and Asset Actions:
- Capital Raise: Atlantic Union intends to raise approximately $400 million of common stock concurrent with the transaction announcement.
- Asset Sale: Atlantic Union anticipates selling approximately $2 billion of commercial real estate (CRE) loans post-closing to reduce concentration and improve liquidity.
Pro Forma Financial Impact (Atlantic Union):
- EPS Accretion: Approximately 23% (Morgan Stanley analysis); 15.5% for 2025 and 22.8% for 2026 (KBW analysis).
- Tangible Book Value (TBV): Dilutive by approximately 8% (Morgan Stanley); 8.2% dilution at closing (KBW).
- Capital Ratios: Common Equity Tier 1 ratio accretive by 0.1% (Morgan Stanley); KBW analysis indicates potential decreases in tangible common equity, Tier 1 Leverage, and Common Equity Tier 1 ratios at closing, with an increase in Total Risk Based Ratio.
Material Changes and Supplemental Disclosures
This filing provides specific updates to the "Background of the Merger" and financial advisor opinions not previously detailed in the proxy statement:
- Board Process: Detailed timeline of board meetings from May to October 2024, including discussions with potential targets (Company B, C, D) and the specific rationale for selecting Sandy Spring.
- Negotiation History: Clarification that Atlantic Union initially offered a 0.85 exchange ratio (3.0% premium) on September 6, 2024, which Sandy Spring rejected as insufficient. The final 0.900 ratio was proposed on September 9, 2024.
- Financial Advisor Fees:
- Morgan Stanley (Atlantic Union): Retained for fairness opinion; held less than 1% of Atlantic Union stock as of October 20, 2024.
- KBW (Sandy Spring): Fee of 1.1% of aggregate merger consideration (estimated $16.8 million total; $2.5 million payable upon opinion, remainder contingent on closing).
- Valuation Multiples: Updated tables showing Price/2025E EPS and Price/TBV multiples for selected peer companies and precedent transactions.
Guidance, Risks, and Contingencies
Legal Contingencies: Three lawsuits (Delman, Miller, Jones) and demand letters allege violations of the Securities Exchange Act and state fiduciary duties. The companies assert claims are without merit but are supplementing disclosures to mitigate litigation risk.
Forward-Looking Risks:
- Failure to obtain regulatory approvals or shareholder votes.
- Integration difficulties and failure to realize anticipated cost savings.
- Changes in interest rates, economic conditions, or asset quality.
- Potential dilution of tangible book value and changes in capital ratios.
- Diversion of management attention from ongoing operations.
Management Commentary: Management believes the merger enhances scale and diversity in Mid-Atlantic markets. The transaction is expected to be accretive to earnings despite short-term dilution to tangible book value.
Investor Verification Checklist
- Merger Agreement Terms: Verify the final exchange ratio (0.900) and the conditions precedent for closing.
- Capital Raise Execution: Confirm the status and pricing of the anticipated $400 million equity offering.
- Asset Sale Progress: Monitor the execution of the $2 billion commercial real estate loan sale to validate liquidity improvements.
- Legal Proceedings: Track the status of the Delman, Miller, and Jones lawsuits to assess potential delays or injunctions.
- Regulatory Approvals: Monitor for approval from the Federal Reserve, OCC, and other relevant banking regulators.
- Pro Forma Accuracy: Compare actual post-merger financial results against the projected 23% EPS accretion and 8% TBV dilution.